EP Patent

EP1525882A1 — Administration form comprising an acid-labile active compound

Assigned to Takeda GmbH · Expires 2005-04-27 · 21y expired

What this patent protects

Novel administration forms for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.

USPTO Abstract

Novel administration forms for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.

Drugs covered by this patent

Patent Metadata

Patent number
EP1525882A1
Jurisdiction
EP
Classification
—
Expires
2005-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Takeda GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.